Daily non-political popular news in brief.

Enzyme may hold key to new treatment of diabetic kidney disease

Northwestern University researchers have found an enzyme, called "ACE2," may hold the potential to treat diabetic kidney disease, the most common form of kidney disease.The researchers have found low levels of the ACE2 enzyme in kidneys of diabetic mice. When ACE2 was further decreased with an inhibitor drug, kidney disease worsened. Studies are now needed using compounds that increase the level of ACE2 in the kidneys of diabetic mice to see if it reverses or prevents kidney disease.

Read more »

Keywords: enzyme, hold, key, treatment, diabetic, kidney, disease

« Previous | Next »

Similar news on "Enzyme may hold key to new treatment of diabetic kidney disease":

1. Pioglitazone lowers cardiovascular risk in diabetic patients with kidney disease
   12-12-2007 · EurekAlert!
   A new study confirms that chronic kidney disease increases the already-high risk of serious cardiovascular events in diabetic patients with damage to the large blood vessels and suggests that treatment with the antidiabetic drug pioglitazone may help to lower this risk, reports the January Journal of the American Society of Nephrology.
   Similar news · Read more »
   
2. Lungs' mast cells could provide new treatment target for asthma, other respiratory disease
   01-29-2008 · EurekAlert!
   An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma -- pointing to a potential new target for treatment against the illness.
   Similar news · Read more »
   
3. Combination therapy stops loss of kidney function in rare genetic disease
   07-25-2007 · EurekAlert!
   A combination of two types of blood pressure-lowering drugs -- an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme, Genzyme Corporation, Cambridge, Mass.) -- is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease, reports a study in the September Journal of the American Society of Nephrology.
   Similar news · Read more »
   
4. ACE inhibitors help preserve kidney function in IgA nephropathy
   05-16-2007 · EurekAlert!
   For young patients with the kidney disease IgA nephropathy, early treatment with angiotensin-converting enzyme inhibitors can reduce the long-term risk of irreversible kidney damage, suggests a study in the June Journal of the American Society of Nephrology.
   Similar news · Read more »
   
5. Metabolic syndrome heightens risk for development of uric-acid kidney stones
   09-13-2007 · UT Southwestern Medical Center
   A few properly placed drops of lissamine green can reveal staining patterns that are key to diagnosing dry eye syndrome earlier than other methods, providing doctors more options for treating the potentially sight-stealing disease, new research at UT Southwestern Medical Center confirms.
   Similar news · Read more »
   
6. Duke researchers find physician resistance hinders diabetics use of cutting edge technology
   10-13-2006 · EurekAlert!
   Diabetic patients who use newer technologies such as insulin pumps and blood glucose monitoring devices are better able to manage their disease and adhere to treatment regimens, with less daily pain, than with conventional treatments, according to Duke University researchers. Yet researchers have found that the newer methods to manage diabetes are not being widely used because physicians may be reluctant to prescribe them, and even patients who are using them may not be deriving their full benefits.
   Similar news · Read more »
   
7. Older patients reap positive benefits with high dose statins
   07-02-2007 · EurekAlert!
   Can older patients with stable cardiovascular disease benefit from the same cholesterol lowering drugs used by younger patients? The answer is yes, according to a study report in the July 3, 2007 issue of the Annals of Internal Medicine. The key to beneficial treatment appears to be dosage, says lead author Nanette K. Wenger, M.D., professor of medicine in the Division of Cardiology, Emory University School of Medicine, and chief of cardiology at Grady Memorial Hospital.
   Similar news · Read more »
   
8. Found in translation: Prioritizing research questions in breast cancer
   11-21-2007 · EurekAlert!
   The key priorities that will impact on the future treatment of breast cancer have been identified by a group of experts on the disease. Research published in the online open access journal Breast Cancer Research may focus research resources onto the issues highlighted as top priorities.
   Similar news · Read more »
   
9. Naturally occurring enzyme can break down key part of Alzheimer's plaques
   10-24-2006 · EurekAlert!
   Scientists have identified a naturally occurring enzyme that can break down a key component of the brain plaques characteristic of Alzheimer's disease. The finding may provide researchers with new opportunities to understand what goes wrong in the brains of Alzheimer's patients and could one day help them seek new therapies.
   Similar news · Read more »
   
10. Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers
    11-08-2006 · EurekAlert!
    Preliminary trials of a MEK enzyme inhibitor have shown that it is capable of producing long-lasting stable disease in patients with advanced solid cancers. Tests showed that the drug inhibited key targets in the patients' tumours, and now it is being tested in phase II clinical trials according to research presented at the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Prague.
    Similar news · Read more »